TITLE

Widespread tenofovir gel use has substantial impact in South Africa

PUB. DATE
June 2011
SOURCE
PharmacoEconomics & Outcomes News;6/25/2011, Issue 631, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses research analysis in 2011 that claims widespread use of tenofovir gel in South Africa could prevent more than two million new HIV infections and save one million lives over 20 years. The research was conducted by the World Health Organization (WHO), the Centre for the AIDS Program of Research in South Africa (CAPRISA) and the Joint United Nations Programme on HIV/AIDS (UNAIDS). The CAPRISA 004 trial reportedly showed that the vaginal microbicide significantly reduces HIV transmission from men to women.
ACCESSION #
62656913

 

Related Articles

Share

Read the Article

Courtesy of ASKRI - RI OFFICE OF LIBRARY AND INFORMATION SERVICES

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics